Form 4 for HCA HCA Healthcare
Accepted 2022-10-28 00:00:00 ET · period of report 2022-10-26 · accession 0001209191-22-054854 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-10-28 | 2022-10-26 | HCA | Billington Phillip G | SVP-Internal Audit Services | M - OptEx | $37.18 | +16.6K | 57.2K | +41% | +$616.3K |
| D | 2022-10-28 | 2022-10-28 | HCA | Billington Phillip G | SVP-Internal Audit Services | S - Sale+OE | $222.58 | -8,332 | 40.7K | -17% | -$1.85M |
| D | 2022-10-28 | 2022-10-26 | HCA | Billington Phillip G | SVP-Internal Audit Services | F - Tax | $217.48 | -8,243 | 49.0K | -14% | -$1.79M |
| DM | 2022-10-28 | 2022-10-26 | HCA | Billington Phillip G | SVP-Internal Audit Services | M - OptEx | $0.00 | -16.6K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-10-26 | M | A | 16,575 | $37.18 | 57,227.11 | D | — | — | (F1) Includes 2,176.1056 shares acquired under the HCA Holdings, Inc. Employee Stock Purchase Plan. |
| 2 | Common | Common Stock | 2022-10-28 | S | D | 8,332 | $222.58 | 40,652.11 | D | — | — | (F2) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $222.50 to $222.77, inclusive. The reporting person undertakes to provide to HCA Healthcare, Inc., any security holder of HCA Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. (F1) Includes 2,176.1056 shares acquired under the HCA Holdings, Inc. Employee Stock Purchase Plan. |
| 3 | Common | Common Stock | 2022-10-26 | F | D | 8,243 | $217.48 | 48,984.11 | D | — | — | (F1) Includes 2,176.1056 shares acquired under the HCA Holdings, Inc. Employee Stock Purchase Plan. |
| 4 | Derivative | Stock Appreciation Right | 2022-10-26 | M | D | 8,500 | $0.00 | 0 | D | $37.18 · — to 2023-02-06 | 8,500 Common Stock | (F3) The stock appreciation rights vested in four equal annual installments beginning on February 6, 2014. |
| 5 | Derivative | Stock Appreciation Right | 2022-10-26 | M | D | 8,075 | $0.00 | 0 | D | $37.18 · — to 2023-02-06 | 8,075 Common Stock | (F4) The stock appreciation rights vested at the end of fiscal years 2013, 2014, 2015 and 2016 based upon the achievement of certain annual EBITDA performance targets. |